On this week’s episode Spiro Kletas, President and CEO of Big North Graphite, as well as, Chad McMillan, Director of Canada Strategic Metals, provide viewers with valuable and interesting information pertaining to both their companies and the fast rising small-cap graphite industry.
SEGMENT 1 – Matt Gowing, research analyst with Mackie Research provides a compelling argument for the future of the graphite market.
SPECIAL FEATURE: Anthony Giovinazzo of Cynapsus Therapeutics then takes the stage to discuss the company’s development of a non-injectable delivery of the only approved drug to be used as a rescue therapy for “off†motor symptoms of Parkinson’s disease as well as their recent financing and a grant from the Michael J. Fox Foundation.
SEGMENT 2 – Spiro Kletas, President and CEO of Big North Graphite discusses the company’s interest in the past producing Nuevo San Pedro project which is an amorphous graphite mine located in Mexico, in a region that has produced graphite for more than 100 years.
Chad McMillan of Canada Strategic Metals then takes the stage to discuss the company’s metallurgical characterization results from a recent work program on the La Loutre graphite property.
SEGMENT 3 – Round Up! Matt Gowing rejoins the guests to discuss the amorphous vs. flake graphite market.